Kafa Travmalı Olgularda Nöroleptik Malign Sendromun Erken Tanı ve Tedavisi
Sinir Sistemi Cerrahisi Dergisi · 2014
DOI: 10.5222/sscd.2014.089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sinir Sistemi Cerrahisi Dergisi, 2014. Verfasst von Hafize Öksüz und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neuroleptic malignant syndrome (NMS), that often onsets with the use of neuroleptics which has no satisfactory treatment is a rare and life-threatening neurological emergency. NMS has some clinical symptoms such as hyperthermia, muscular rigidity, autonomic dysfunction, consciousness disorders and laboratory findings such as higher serum creatinine phosphokinase (CPK) levels, and leukocytosis. Risk factors include adolescent age, male gender, electrolyte disturbances, dehydration, low serum iron level, use of antiemetics, mental retardation, trauma, organic brain syndrome, extrapiramidal disorders (such as Parkinson’s disease), alcoholism and malnutrition. In this article, three cases of NMS who had been treated in the intensive care unit because of traumatic brain injury (TBI) are presented. Also the diagnosis and treatment of NMS have been discussed.
Zitieren
APA
Öksüz, H., Doğu, B., Arslan, M., Gişi, G., Yavuz, C., Bahar, Ş., Yüksel, Z., & Uygungelen, A. (2014). Kafa Travmalı Olgularda Nöroleptik Malign Sendromun Erken Tanı ve Tedavisi. Sinir Sistemi Cerrahisi Dergisi. https://doi.org/10.5222/sscd.2014.089
Vancouver
Öksüz H, Doğu B, Arslan M, Gişi G, Yavuz C, Bahar Ş, et al. Kafa Travmalı Olgularda Nöroleptik Malign Sendromun Erken Tanı ve Tedavisi. Sinir Sistemi Cerrahisi Dergisi. 2014. doi:10.5222/sscd.2014.089
BibTeX
@article{ksz2014,
author = {Öksüz, Hafize and Doğu, Birsen and Arslan, Mahmut and Gişi, Gökçe and Yavuz, Cengizhan and Bahar, Şeyma and Yüksel, Zafer and Uygungelen, Arzu},
title = {Kafa Travmalı Olgularda Nöroleptik Malign Sendromun Erken Tanı ve Tedavisi},
journal = {Sinir Sistemi Cerrahisi Dergisi},
year = {2014},
doi = {10.5222/sscd.2014.089}
}
EUVIMED